Pentagon Mandates Testosterone Testing for Male Service Members 30 and Older

The Pentagon has released formal guidance for mandatory testosterone testing for male service members aged 30 and older, a policy aimed at enhancing military readiness. The program, announced by Defense Secretary Pete Hegseth in July, seeks to identify and treat "testosterone deficiency" to ensure service members can perform at their peak.

The new clinical guidance specifies that the testing will initially apply only to male troops. While Hegseth's initial memo suggested screenings for all service members, the released document focuses on "testosterone deficiency in the male service member." Guidance for female service members is under review and will be posted upon approval.

Testosterone levels naturally decline with age, potentially affecting sexual function, mood, and bone density. Recent federal studies have indicated that boosting testosterone can improve issues such as erectile dysfunction and low libido in men. The Pentagon's top spokesman, Sean Parnell, stated that the initiative is an investment in service members' health and performance.

However, the Pentagon's approach deviates from typical medical recommendations. Generally, medical guidelines suggest testosterone therapy for men experiencing symptoms like low libido or depressed mood, coupled with confirmation of low levels through two blood tests. The Pentagon's policy, conversely, mandates screening for all male personnel 30 and older and allows younger members to request testing.

The new guidelines acknowledge limitations in testosterone replacement therapy, stating that evidence does not support its use for improving energy, vitality, physical function, or cognition. Benefits are primarily noted for sexual function and certain physical measures like bone density.

The policy also addresses potential side effects and practical considerations. Military doctors are instructed not to prescribe testosterone therapy to individuals planning to have children soon, as external testosterone can reduce or halt natural sperm production. Furthermore, the guidance highlights challenges related to administering testosterone in deployed environments, including requirements for controlled storage and accountability of the substance. Injectable testosterone requires specific temperature-controlled storage and adherence to controlled substance regulations, and troops must ensure an adequate supply, navigating federal limitations on prescriptions for such substances.